Details
Surgeon Early Observations
Product Technology
These videos include references to the use of a surgical device and the opinions of the individual presenter. The videos may also include references to medical devices still in development or available for investigational use only and represents scientific exchange.
The Founders of the Technology
GT Metabolic founders Thierry Thaure and Michel Gagner, MD, are renowned global experts in the area of bariatric and metabolic procedures. They’ve led the GT Metabolic team in engineering a magnetic compression solution called delayed anastomosis technology (DAT) that surgeons can use to create consistent anastomosis while helping minimize potential complications.

Thierry Thaure
CEO & Co-founder

Michel Gagner, MD
CMO & Co-founder
Sources:
1. De Novo marketing authorization DEN240013. MagDI™ System for side-to-side duodeno-ileal anastomosis granted De Novo marketing authorization from the U.S. Food and Drug Administration (FDA). 2 July 2024. The second-generation MagDI™ System with the 40mm DI Magnet and 50mm DI Magnet received U.S. FDA 510(k) clearances in October 2024 and February 2025 respectively (K242086, K243359).
2. Gagner, M., Almutlaq, L., Cadiere, G.-B., Torres, A. J., Sanchez-Pernaute, A., Buchwald, J. N., & Abuladze, D. (2023). Side-to-side magnetic duodeno-ileostomy in adults with severe obesity with or without type 2 diabetes: Early outcomes with prior or concurrent sleeve gastrectomy. Surgery for Obesity and Related Diseases. https://doi.org/10.1016/j.soard.2023.10.018
3. Gagner, M., Abuladze, D., Koiava, L. et al.First-in-Human Side-to-Side Magnetic Compression Duodeno-ileostomy with the Magnet Anastomosis System. OBES SURG 33, 2282–2292 (2023). https://doi.org/10.1007/s11695-023-06708-x
4. Gagner M, Cadiere GB, Sanchez-Pernaute A, Abuladze D, Krinke T, Buchwald JN, Van Sante N, Van Gossum M, Dziakova J, Koiava L, Odovic M, Poras M, Almutlaq L, Torres AJ. Side-to-side magnet anastomosis system duodeno-ileostomy with sleeve gastrectomy: early multi-center results. Surg Endosc. 2023 Aug;37(8):6452-6463. doi: 10.1007/s00464-023-10134-6. Epub 2023 May 22. PMID: 37217682; PMCID: PMC10202352.
5. Gagner, M., Abuladze, D., Buchwald, J., et al. First-in-Human Side-to-Side Duodenoileal Bipartition for Weight Loss and Type 2 Diabetes with the Swallowable Biofragmentable Magnetic Anastomosis System. JACS 241(2):p 146-159, August 2025. https://doi.org/10.1097/XCS.0000000000001384.











